Biotech 2008 to Feature Cephalon CEO, Frank Baldino, Jr., Ph.D. as Luncheon Keynote Speaker -
JP MORGAN'S CHRIS SCHOTT ASSUMES CEPHALON INC COVERAGE WITH OVERWEIGHT RATING -
Cephalon Slumps Below 200-Day Moving Average -
CEPH touches 200-day moving average at 67.47 -
Settlement to yield $438,000 for Utah -
BRIEF: Drug company to pay AG's office, other states -
Cephalon fined $437M for pushing 'off-label' use -
Cephalon settles charges for $425 million -
Cephalon To Pay $425 Million To Settle Claims For Improper Drug Marketing -
Cephalon finalizes $425M to settle federal charges -
Cephalon To Pay $425 Mln. To Settle improper Marketing Claims - update -
Ohio Sales Rep's Information Launched Massive Government Investigation of Cephalon -
Cephalon to pay $425 million to settle federal cases -
$425 Million Cephalon Civil Settlement and Criminal Fine; In America's Largest -
Cephalon Set New High for Year Friday -
Cephalon Finishes At 14-Month High -
Cephalon (CEPH) NewsBite - CEPH Hits 52-Week High -